InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2025-09-11 00:00:00 ET · period of report 2025-09-09 · accession 0001415889-25-024271 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-09-11 2025-09-09 WGS Stueland Katherine CEO, Dir S - Sale+OE $128.06 -3,657 6,329 -37% -$468.3K
D 2025-09-11 2025-09-09 WGS Stueland Katherine CEO, Dir M - OptEx $0.00 +6,546 9,986 +190% $0
D 2025-09-11 2025-09-09 WGS Stueland Katherine CEO, Dir M - OptEx $0.00 -6,546 32.7K -17% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-09-09 S D 3,639 $128.05 6,347 D — —
2 Common Class A Common Stock 2025-09-09 M A 6,546 $0.00 9,986 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
3 Common Class A Common Stock 2025-09-09 S D 18 $129.08 6,329 D — — (F3) Following the reported sales, in addition to the 6,329 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 463,289 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms.
4 Derivative Restricted Stock Unit 2025-09-09 M D 6,546 $0.00 32,733 D — · — to — 6,546 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F4) 6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.